What is peptide therapy?
Peptide therapy is a type of treatment used for autoimmune disorders, multiple sclerosis, Parkinson's disease and some types of allergies. These therapies are based on the idea that peptides can be used and manipulated to help the body fight certain diseases and diseases. Although many research is still needed, some patients have shown significant progress and improvements.
Peptides are specific compounds in the body. They are the result of two amino acids. Peptide can be multifunctional and can function as a protein, hormone or help in the digestion process. Exactly how peptide functions depend on the type of treatment and condition. This manipulation is a large contributing factor in what makes peptide therapy potentially beneficial.
Sclerosis is one of the candidates for peptide therapy. Peptides change in this treatment. The specific protein segment, myelin basic protein (MBP) has changed. Changed protein of the peptide ligand (APL) Therapy is a term used to describe this manipulation. PatiaNTI with multiple sclerosis suffers from the ignition of myelin, which is assumed to be attacked by the body, leading to an increase in symptoms.
Peptide therapy can also be used to treat autoimmune problems. In autoimmune conditions, inflammatory cells support the development of antigens that focus and damage tissue. For this treatment, T cell receptor proteins are targeted and changed. Changed peptides are then used to combat inflammatory t cells and reduce or prevent tissue destruction. Peptide therapies can benefit specific conditions such as rheumatoid arthritis.
Antibiotics are considered to be forms of peptide therapy, especially antibiotics that target a gram of negative and positive bacteria that rely on changed proteins because these bacteria are resistant to standard treatment. In some case, peptide therapy can also be used to help people with compromised immunesystems. The use of changed peptides can help increase the ability of a weakened immune system to fight antigens.
In the same way as the treatment of multiple sclerosis, peptide therapy showed the potential for people suffering from Parkinson's disease. The symptoms of this disease are partly caused by slow destruction of cells in the middle of the brain and lead to a reduction in dopamine, resulting in chemical imbalance. When dopamine levels are low, there are problems with tremor, slow movement and equilibrium problems. Scientists believe that an increase in a specific protein called NF-KB can be focused on changed peptides. Injection of these peptides has shown some potential in blocking this protein.